AU2456701A - Pharmaceutical and veterinary uses of endothelin antagonists - Google Patents

Pharmaceutical and veterinary uses of endothelin antagonists

Info

Publication number
AU2456701A
AU2456701A AU24567/01A AU2456701A AU2456701A AU 2456701 A AU2456701 A AU 2456701A AU 24567/01 A AU24567/01 A AU 24567/01A AU 2456701 A AU2456701 A AU 2456701A AU 2456701 A AU2456701 A AU 2456701A
Authority
AU
Australia
Prior art keywords
pharmaceutical
endothelin antagonists
veterinary uses
veterinary
endothelin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24567/01A
Inventor
Thomas A. Brock
Patrick R. Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encysive Pharmaceuticals Inc
Original Assignee
Texas Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas Biotechnology Corp filed Critical Texas Biotechnology Corp
Publication of AU2456701A publication Critical patent/AU2456701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU24567/01A 1999-12-31 2000-12-27 Pharmaceutical and veterinary uses of endothelin antagonists Abandoned AU2456701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17412599P 1999-12-31 1999-12-31
US60174125 1999-12-31
PCT/US2000/035280 WO2001049289A1 (en) 1999-12-31 2000-12-27 Pharmaceutical and veterinary uses of endothelin antagonists

Publications (1)

Publication Number Publication Date
AU2456701A true AU2456701A (en) 2001-07-16

Family

ID=22634931

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24567/01A Abandoned AU2456701A (en) 1999-12-31 2000-12-27 Pharmaceutical and veterinary uses of endothelin antagonists

Country Status (2)

Country Link
AU (1) AU2456701A (en)
WO (1) WO2001049289A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1402890B1 (en) * 2001-06-08 2008-01-09 Institute of Medicinal Molecular Design, Inc. Sulfonamide derivatives
CA2515780C (en) * 2003-02-20 2012-12-11 Encysive Pharmaceuticals Inc. Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
US7288538B2 (en) 2003-02-20 2007-10-30 Encysive Pharmaceuticals, Inc. Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
DE102004005787A1 (en) * 2004-02-06 2005-08-25 Bayer Cropscience Ag carboxamides
US20080070961A1 (en) * 2006-08-04 2008-03-20 Reichwein John F Polymorphs of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamide
JP5361857B2 (en) 2007-03-23 2013-12-04 ファイザー・リミテッド Ion channel inhibitors
US8993617B2 (en) 2010-11-10 2015-03-31 The Board Of Trustees Of The Leland Stanford Junior University Ire1alpha endonuclease specific inhibitor with cytotoxic activity
TW201512171A (en) 2013-04-19 2015-04-01 Pfizer Ltd Chemical compounds
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
CA3143666A1 (en) 2019-06-18 2020-12-24 Pfizer Inc. Benzisoxazole sulfonamide derivatives
WO2021211839A1 (en) * 2020-04-17 2021-10-21 Escient Pharmaceuticals, Inc. Modulators of mas-related g-protein receptor x4 and related products and methods
CN113607525A (en) * 2021-08-09 2021-11-05 安徽信灵检验医学科技股份有限公司 Vacuum blood collection tube additive for blood digestion and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281207A (en) * 1993-08-28 1995-03-01 Univ Sheffield Treatment of laminitis with l-arginine
DE69426986T2 (en) * 1993-08-28 2001-10-25 Univ Sheffield Sheffield TREATMENT OF LAMINITIS
GB2292520B (en) * 1994-08-25 1998-09-02 Univ Sheffield Transdermal dressings for animals
TR199701096T1 (en) * 1995-04-04 1998-02-21 Texas Biotechnology Corporation Tienil-, Furil-, Pyrrolil- ve Bifenils�lfonamidler ve Bunlar�n Endotelin Etkinli�ini D�zenleyen T�revleri.
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
HU227183B1 (en) * 1997-04-28 2010-09-28 Encysive Pharmaceuticals Inc Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
EP2002837A1 (en) * 1998-07-06 2008-12-17 Bristol-Myers Squibb Company Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists

Also Published As

Publication number Publication date
WO2001049289A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
HUP0200548A2 (en) Pharmaceutical compositions and their use
AU5440901A (en) Cosmetic and/or pharmaceutical preparations
AU2319100A (en) Amide derivatives and drug compositions
AU2223201A (en) Quinoline and quinazoline derivatives and drugs containing the same
PL354168A1 (en) Pharmaceutical composition of nateglinide and another antidiabetcagent
AU3620600A (en) Skin-marking devices and their use
HUP0103874A3 (en) Use of antibiotics and pharmaceutical compositions comprising thereof
AUPQ969800A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU5326100A (en) Pharmaceutical compositions and methods for use
AU1164601A (en) Therapeutic use and formulation
PL342500A1 (en) Derivatives of pyrolydin-3-carboxylic acid and their application as endothelin antagonists
AU2456701A (en) Pharmaceutical and veterinary uses of endothelin antagonists
HUP0203121A3 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
AU2001288061A1 (en) Drug resistance-associated gene and use thereof
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU1730201A (en) Proteoglycans and pharmaceutical compositions comprising them
AU7271600A (en) Quinazolinone and azaquinazolinone derivatives
AU2438400A (en) Cosmetic and/or pharmaceutical preparations
AU4293800A (en) Cosmetic and/or pharmaceutical preparations
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU6179600A (en) Peptides and pharmaceutical compositions comprising same
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU4543500A (en) Pharmaceutical compositions and uses
AU6866700A (en) Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
HUP0200812A3 (en) Vitamin d analogues and their pharmaceutical use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase